newsfilter
← Latest News
Business Wire·

Gilead Prices $3 Billion of Senior Unsecured Notes

Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, today announced the pricing of senior unsecured notes in an aggregate